Form 4: MYGN CFO Sells Shares for Tax Obligations

Myriad Genetics' Chief Financial Officer, Benjamin Richard Wheeler, disposed of 2,559 shares of common stock to cover tax withholding obligations related to restricted stock unit vesting.

Summary

• Benjamin Richard Wheeler, Chief Financial Officer of Myriad Genetics Inc. (MYGN), reported a transaction on September 21, 2025.
• The transaction involved the disposition of 2,559 shares of MYGN common stock.
• These shares were withheld by the company to satisfy tax withholding obligations associated with the vesting of restricted stock units.
• The shares were valued at $7.77 each, based on the closing price on September 19, 2025.
• Following this transaction, Mr. Wheeler beneficially owns 92,651 shares of MYGN common stock directly.

Sentiment

Score: 5

Explanation: This is a routine insider transaction for tax purposes, indicating no significant positive or negative sentiment regarding the company's prospects. It's a neutral event.

Negatives

• Benjamin Richard Wheeler's direct beneficial ownership of Myriad Genetics common stock decreased by 2,559 shares due to tax withholding.

Stakeholder Impact

• Shareholders: Minor dilution from the shares being withheld by the company, but this is a standard part of equity compensation plans and generally not material.
• Employees (specifically the CFO): The transaction represents the realization of value from previously granted equity compensation.

Key Dates

Keywords

Myriad Genetics, MYGN, Benjamin Richard Wheeler, CFO, Form 4, Insider Transaction, Stock Sale, Tax Withholding, Restricted Stock Units, Equity Compensation